PKG-Modified TSC2 Regulates mTORC1 Activity to Counter Adverse Cardiac Stress
暂无分享,去创建一个
Dong I. Lee | D. Kass | J. V. Van Eyk | M. Sasaki | J. Powell | Chirag H. Patel | R. Holewinski | D. Bedja | Guangshuo Zhu | Taishi Nakamura | J. V. Van Eyk | Kristen M. Kokkonen-Simon | Anna Chen | M. Ranek | C. Oeing | B. Dunkerly-Eyring | M. P. Vera
[1] J. Sadoshima,et al. New Insights Into the Role of mTOR Signaling in the Cardiovascular System. , 2018, Circulation Research.
[2] David M. Sabatini,et al. mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.
[3] D. Kass,et al. Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease. , 2016, Handbook of experimental pharmacology.
[4] Jenna Scotcher,et al. Disulfide-activated protein kinase G Iα regulates cardiac diastolic relaxation and fine-tunes the Frank–Starling response , 2016, Nature Communications.
[5] Michael L. Gatza,et al. Proteogenomics connects somatic mutations to signaling in breast cancer , 2016, Nature.
[6] A. Shah,et al. mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy , 2016, PloS one.
[7] Dong I. Lee,et al. Prevention of PKG1α oxidation augments cardioprotection in the stressed heart. , 2015, The Journal of clinical investigation.
[8] Thomas Danner,et al. Phosphodiesterase 9A Controls Nitric-oxide Independent cGMP and Hypertrophic Heart Disease , 2015, Nature.
[9] D. Kwiatkowski,et al. Coordinated regulation of protein synthesis and degradation by mTORC1 , 2014, Nature.
[10] Donald J. Zack,et al. Expansion of the CRISPR-Cas9 genome targeting space through the use of H1 promoter-expressed guide–RNAs , 2014, Nature Communications.
[11] L. Cantley,et al. Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosome , 2014, Cell.
[12] David A. Scott,et al. Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.
[13] B. Turk,et al. Cyclic GMP-dependent Stimulation of Serotonin Transport Does Not Involve Direct Transporter Phosphorylation by cGMP-dependent Protein Kinase* , 2012, Journal of Biological Chemistry.
[14] T. Alain,et al. Pharmacological and Genetic Evaluation of Proposed Roles of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (MEK), Extracellular Signal-regulated Kinase (ERK), and p90RSK in the Control of mTORC1 Protein Signaling by Phorbol Esters* , 2011, The Journal of Biological Chemistry.
[15] N. Hariharan,et al. Oxidative stress stimulates autophagic flux during ischemia/reperfusion. , 2011, Antioxidants & redox signaling.
[16] M. Hall,et al. Cardiac Raptor Ablation Impairs Adaptive Hypertrophy, Alters Metabolic Gene Expression, and Causes Heart Failure in Mice , 2011, Circulation.
[17] B. Viollet,et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.
[18] M. Latronico,et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. , 2010, The Journal of clinical investigation.
[19] K. Nakao,et al. Inhibition of TRPC6 Channel Activity Contributes to the Antihypertrophic Effects of Natriuretic Peptides-Guanylyl Cyclase-A Signaling in the Heart , 2010, Circulation research.
[20] D. Kuppuswamy,et al. Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCε and PKCδ, in adult cardiac muscle cells , 2007 .
[21] Alma L Burlingame,et al. A semisynthetic epitope for kinase substrates , 2007, Nature Methods.
[22] Ming You,et al. TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth , 2006, Cell.
[23] Paul Tempst,et al. Phosphorylation and Functional Inactivation of TSC2 by Erk Implications for Tuberous Sclerosisand Cancer Pathogenesis , 2005, Cell.
[24] D. Kass,et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy , 2005, Nature Medicine.
[25] Steven P Gygi,et al. Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[26] Steven P Gygi,et al. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[27] K. Inoki,et al. TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.
[28] Hongbing Zhang,et al. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. , 2003, The Journal of clinical investigation.
[29] Tian Xu,et al. Akt regulates growth by directly phosphorylating Tsc2 , 2002, Nature Cell Biology.
[30] D. Kuppuswamy,et al. Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCepsilon and PKCdelta, in adult cardiac muscle cells. , 2007, Journal of Molecular and Cellular Cardiology.